Key to HF Drug Benefit Lies in Heart Rate

HFC 2012 — BELGRADE, Serbia — The heart rate reduction achieved with ivabradine determines its impact for heart failure patients who can't tolerate much beta-blocker therapy, researchers found.


< Back to Listings